(Q36968194)

17 August 2017

1 reference

title

Aralast: an alpha 1-protease inhibitor for the treatment of alpha-antitrypsin deficiency (English)

1 reference

17 August 2017

author name string

Nicholas M Mordwinkin

series ordinal

1

1 reference

17 August 2017

Stan G Louie

series ordinal

2

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

Expert Opinion on Pharmacotherapy

17 August 2017

published in

1 reference

17 August 2017

volume

8

1 reference

17 August 2017

issue

15

1 reference

17 August 2017

page(s)

2609-2614

1 reference

Alpha1-antitrypsin deficiency

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2609

Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2609

Bronchiectasis in patients with alpha 1-antitrypsin deficiency. A rare occurrence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2609

Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2609

Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2609

Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2609

Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2609

Alpha1-Antitrypsin Deficiency-Associated Panniculitis: Case Report and Review of the Literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2609

Delay in diagnosis of alpha1-antitrypsin deficiency: a continuing problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2609

Aralast: a new alpha1-protease inhibitor for treatment of alpha-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2609

Biochemical efficacy and safety of a new pooled human plasma alpha(1)-antitrypsin, Respitin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2609

Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2609

Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2609

Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2609

10.1517/14656566.8.15.2609

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference